HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The combination of ibuprofen and oxycodone/acetaminophen in the management of chronic cancer pain.

Abstract
Thirty subjects with chronic moderate to severe pain who were receiving oxycodone/acetaminophen (oxy/APAP) for analgesia were initially evaluated for at least 7 days for oxy/APAP requirements for pain control. Each subject then received, in a randomized double-blind fashion, either 600 mg ibuprofen or placebo for an additional 7 days while hospitalized. Oxy/APAP usage was recorded daily along with efficacy and toxicity parameters. Overall global evaluations were also recorded on completion of the study. Comparison of mean differences before and after treatment with ibuprofen or placebo indicated a marked decrease in oxy/APAP use with ibuprofen (p less than 0.01) and a slight increase in use in the placebo group. Reduction in oxy/APAP usage occurred within 24 hours and maximized at 5 days. Overall global scores showed a marked preference for the ibuprofen combination over placebo (p less than 0.01). Daily pain intensity (p less than 0.05) and pain relief scores (p less than 0.05) also improved with the addition of ibuprofen. This study indicates that ibuprofen is efficacious in the management of chronic cancer pain, resulting in both enhanced analgesia and a reduction in concomitant narcotic use.
AuthorsJ E Stambaugh Jr, J Drew
JournalClinical pharmacology and therapeutics (Clin Pharmacol Ther) Vol. 44 Issue 6 Pg. 665-9 (Dec 1988) ISSN: 0009-9236 [Print] United States
PMID2461823 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetaminophen
  • Oxycodone
  • Codeine
  • Ibuprofen
Topics
  • Acetaminophen (administration & dosage, therapeutic use)
  • Adult
  • Aged
  • Analysis of Variance
  • Bone Neoplasms (complications, secondary)
  • Chronic Disease
  • Codeine (analogs & derivatives)
  • Double-Blind Method
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Ibuprofen (administration & dosage, therapeutic use)
  • Male
  • Middle Aged
  • Oxycodone (administration & dosage, therapeutic use)
  • Pain (etiology, prevention & control)
  • Palliative Care
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: